Bills · HR 4191
IN COMMITTEE· 119TH CONGRESS
House BillHR 4191Strategic materials and reservesSupply chain
MAPS Act
INTRO JUN 26· LAST ACTION JUN 26
READING
8MIN
COSPONSORS
2
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it directly addresses a critical concern for public health and national security: the vulnerability of our medicine supply chains. Recent global events have highlighted how easily disruptions can lead to shortages of life-saving drugs, impacting everything from routine medical care to emergency responses.
If this bill becomes law, the U.S. government will have a much clearer picture of where essential medicines and their ingredients are produced, identifying over-reliance on foreign suppliers or single sources. This improved transparency and data-driven understanding could allow the government to proactively address potential weaknesses, reducing the risk of future drug shortages and ensuring Americans have access to the medications they need during crises or for ongoing health conditions. Without this bill, the U.S. would continue to operate with less insight into these critical supply chains, potentially leaving the nation vulnerable to future disruptions.
KEY PROVISIONS
4AI-extractedPROVISION 01
Requires the Secretary of Health and Human Services to update and maintain an 'Essential Medicines List' of critical drugs, reviewing it at least every two years and publishing updates.
This ensures a clear, up-to-date understanding of which medicines are most vital for public health and national security, focusing government efforts.
PROVISION 02
Mandates comprehensive risk assessments of the supply chains for all drugs on the Essential Medicines List, identifying vulnerabilities like reliance on foreign or single suppliers.
This proactive identification of weaknesses allows for strategic planning to mitigate potential shortages and ensure a stable supply of critical drugs.
PROVISION 03
Establishes a system to map and visualize the entire supply chain of essential medicines, from raw materials to finished products, using data analytics.
Visualizing supply chains helps pinpoint specific points of failure or bottlenecks more effectively, improving the government's ability to respond to and prevent disruptions.
PROVISION 04
Requires coordination and information sharing among federal agencies, and potentially public-private partnerships, to facilitate supply chain monitoring and vulnerability assessment.
Collaborative information exchange is crucial for a complete and accurate understanding of complex, global pharmaceutical supply chains.
SPONSORSHIP
1 + 2
D· California
YRS IN OFFICE
21
BILLS LED
29
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 0 REP 2 IND 0
ACTION TIMELINE
2 EVENTSJUN 26
Introduced in House
JUN 26
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 4191
Congress119th
StatusIn Committee
IntroducedJun 26, 2025
Last actionJun 26, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED JUN 26, 2025
House BillHR 4191Strategic materials and reservesSupply chain
MAPS Act
INTRODUCED JUN 26, 2025· LAST ACTION JUN 26, 2025
PASSAGE CHANCES
—%
READING
8 min
COSPONSORS
2
COMPLEXITY
Moderate
